Criterium, Inc.   Report issue

For profit Phase 2
Founded: Pennington NJ United States (1991)

Organization Overview

First Clinical Trial
2011
NCT01464034
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Criterium, Inc. | Criterium Inc., d.b.a. Academic GI Cancer Consortium (AGICC)